Investors

Shareholder Tools

 

News & Events

Upcoming Events
Details on upcoming events are not yet available. Please click here to be notified of all upcoming events.

Archived Events
Aug 3, 2010
8:00 AM ET
Wedbush Life Sciences Best Ideas Conference 2010
Webcast Listen to webcast
Show Additional Information
Apr 26, 2010 Thirteenth Annual Conference on Vaccine Research
PDF View Presentation  88.8 KB   Add to Briefcase
Show Additional Information
Apr 14, 2010 National Kidney Foundation Spring Clinical Meeting
PDF View Presentation  76.5 KB   Add to Briefcase
Show Additional Information

Add to Briefcase = add file to Briefcase
All Releases
View Summary NIAID Grant to Fund Dynavax Research on Hepatitis B Vaccination and Individual Variations in Human Responsiveness
Aug 31, 2010
PDF 7.3 KB Add to Briefcase
View Summary Dynavax Reports 2010 Second Quarter Financial Results
Jul 30, 2010
PDF 15.0 KB Add to Briefcase
View Summary Dynavax to Present at the Wedbush Life Sciences Conference
Jul 29, 2010
PDF 7.2 KB Add to Briefcase
View Summary Dynavax Promotes J. Tyler Martin, M.D. to President
Jul 27, 2010
PDF 7.5 KB Add to Briefcase
View Summary Dynavax Completes Enrollment and First Immunizations in Universal Flu Vaccine Study
Jul 27, 2010
PDF 9.2 KB Add to Briefcase
View Summary Dynavax Reports New Employment Inducement Awards
Jul 23, 2010
PDF 7.0 KB Add to Briefcase
View Summary Dynavax Appoints Daniel Kisner, M.D. to Board of Directors
Jul 22, 2010
PDF 7.5 KB Add to Briefcase
View Summary Dynavax Initiates First Human Trial in Universal Flu Vaccine Program
Jul 7, 2010
PDF 10.1 KB Add to Briefcase
View Summary Dynavax Awarded NIH Grant to Explore Feasibility of Universal Papilloma Virus Vaccine
Jul 6, 2010
PDF 7.0 KB Add to Briefcase
View Summary NATURE Publishes New Dynavax Findings on Novel Role of TLRs in Lupus
Jun 16, 2010
PDF 9.9 KB Add to Briefcase
View Summary Dynavax's Two Phase 3 HEPLISAV Trials Cleared by DSMB to Continue Immunizations
May 27, 2010
PDF 9.3 KB Add to Briefcase
View Summary Dynavax Completes Over 2000 First Immunizations in Phase 3 Study
May 6, 2010
PDF 9.5 KB Add to Briefcase
View Summary Dynavax Reports 2010 First Quarter Financial Results
May 6, 2010
PDF 14.3 KB Add to Briefcase
View Summary Dynavax's Two Phase 3 HEPLISAV Trials Cleared by DSMB to Continue Immunizations
Apr 27, 2010
PDF 9.3 KB Add to Briefcase
View Summary Dynavax Reports Positive Data on Universal Flu Vaccine Candidate
Apr 26, 2010
PDF 10.3 KB Add to Briefcase
View Summary Dynavax's Chronic Kidney Disease Study Confirms HEPLISAV's Enhanced Seroprotection Against HBV Infection
Apr 14, 2010
PDF 11.1 KB Add to Briefcase
View Summary Dynavax Raises $44 Million Through Public Offering of Common Stock and Warrants
Apr 13, 2010
PDF 10.4 KB Add to Briefcase
View Summary Dynavax Announces New Employment Inducement Awards
Apr 9, 2010
PDF 7.2 KB Add to Briefcase
View Summary Dynavax Reports Positive Findings From Detailed Safety Analysis of HEPLISAV(TM)
Mar 23, 2010
PDF 12.6 KB Add to Briefcase
View Summary Dynavax Anticipates Earlier BLA Submission for HEPLISAV(TM)
Mar 16, 2010
PDF 18.3 KB Add to Briefcase
Showing 1-20 of 229 Page: 1 2 3 ... 12  Next 20
=add release to Briefcase